Bryant David Lim - Mar 1, 2023 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Chief Legal Officer, Corp Sec.
Signature
/s/ Bryant D. Lim
Stock symbol
PRLD
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:06 PM
Previous filing
Feb 22, 2023
Next filing
May 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (Right to Buy) Award $0 +250K $0.00 250K Mar 1, 2023 Common Stock 250K $5.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on March 1, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.